222 related articles for article (PubMed ID: 27539728)
21. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
22. Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles.
Li S; Johnson J; Peck A; Xie Q
J Transl Med; 2017 Jan; 15(1):18. PubMed ID: 28114956
[TBL] [Abstract][Full Text] [Related]
23. A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer.
Lv W; Shen Y; Yang H; Yang R; Cai W; Zhang J; Yuan L; Duan Y; Zhang L
J Immunol Res; 2018; 2018():6202876. PubMed ID: 29854844
[TBL] [Abstract][Full Text] [Related]
24. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
[TBL] [Abstract][Full Text] [Related]
25. A new strategy for accurate targeted diagnosis and treatment of cutaneous malignant melanoma: dual-mode phase-change lipid nanodroplets as ultrasound contrast agents.
Yang H; Cai W; Lv W; Zhao P; Shen Y; Zhang L; Ma B; Yuan L; Duan Y; Yao K
Int J Nanomedicine; 2019; 14():7079-7093. PubMed ID: 31564866
[TBL] [Abstract][Full Text] [Related]
26. Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation.
Perera RH; Solorio L; Wu H; Gangolli M; Silverman E; Hernandez C; Peiris PM; Broome AM; Exner AA
Pharm Res; 2014 Jun; 31(6):1407-17. PubMed ID: 23943542
[TBL] [Abstract][Full Text] [Related]
27. Perfluoropentane-filled chitosan poly-acrylic acid nanobubbles with high stability for long-term ultrasound imaging
Gao X; Guo D; Mao X; Shan X; He X; Yu C
Nanoscale; 2021 Mar; 13(10):5333-5343. PubMed ID: 33659972
[TBL] [Abstract][Full Text] [Related]
28. Application of luteinizing hormone-releasing hormone-ferrosoferric oxide nanoparticles in targeted imaging of breast tumors.
Nian D; Shi P; Sun J; Ren L; Hao X; Han J
J Int Med Res; 2019 Apr; 47(4):1749-1757. PubMed ID: 30880516
[TBL] [Abstract][Full Text] [Related]
29. Annexin V conjugated nanobubbles: A novel ultrasound contrast agent for in vivo assessment of the apoptotic response in cancer therapy.
Zhou T; Cai W; Yang H; Zhang H; Hao M; Yuan L; Liu J; Zhang L; Yang Y; Liu X; Deng J; Zhao P; Yang G; Duan Y
J Control Release; 2018 Apr; 276():113-124. PubMed ID: 29522835
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound molecular imaging of ovarian cancer with CA-125 targeted nanobubble contrast agents.
Gao Y; Hernandez C; Yuan HX; Lilly J; Kota P; Zhou H; Wu H; Exner AA
Nanomedicine; 2017 Oct; 13(7):2159-2168. PubMed ID: 28603079
[TBL] [Abstract][Full Text] [Related]
31. Nanobubbles are Non-Echogenic for Fundamental-Mode Contrast-Enhanced Ultrasound Imaging.
Myers JZ; Navarro-Becerra JA; Borden MA
Bioconjug Chem; 2022 Jun; 33(6):1106-1113. PubMed ID: 35476906
[TBL] [Abstract][Full Text] [Related]
32. Combined legumain- and integrin-targeted nanobubbles for molecular ultrasound imaging of breast cancer.
Mi X; Guo X; Du H; Han M; Liu H; Luo Y; Wang D; Xiang R; Yue S; Zhang Y; Tan X
Nanomedicine; 2022 Jun; 42():102533. PubMed ID: 35150904
[TBL] [Abstract][Full Text] [Related]
33. Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents.
Wu H; Rognin NG; Krupka TM; Solorio L; Yoshiara H; Guenette G; Sanders C; Kamiyama N; Exner AA
Ultrasound Med Biol; 2013 Nov; 39(11):2137-46. PubMed ID: 23932272
[TBL] [Abstract][Full Text] [Related]
34. Preparation and Imaging Investigation of Dual-targeted C
Du J; Li XY; Hu H; Xu L; Yang SP; Li FH
Sci Rep; 2018 Mar; 8(1):3887. PubMed ID: 29497045
[TBL] [Abstract][Full Text] [Related]
35. Novel DiR and SPIO nanoparticles embedded PEG-PLGA nanobubbles as a multimodalimaging contrast agent.
Luo B; Zhang H; Liu X; Rao R; Wu Y; Liu W
Biomed Mater Eng; 2015; 26 Suppl 1():S911-6. PubMed ID: 26406092
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation.
Zhang X; Zheng Y; Wang Z; Huang S; Chen Y; Jiang W; Zhang H; Ding M; Li Q; Xiao X; Luo X; Wang Z; Qi H
Biomaterials; 2014 Jun; 35(19):5148-61. PubMed ID: 24680663
[TBL] [Abstract][Full Text] [Related]
37. Intracellular vesicle entrapment of nanobubble ultrasound contrast agents targeted to PSMA promotes prolonged enhancement and stability
Perera RH; Abenojar E; Nittayacharn P; Wang X; Ramamurthy G; Peiris P; Bederman I; Basilion JP; Exner AA
Nanotheranostics; 2022; 6(3):270-285. PubMed ID: 35223380
[TBL] [Abstract][Full Text] [Related]
38. Time-intensity-curve Analysis and Tumor Extravasation of Nanobubble Ultrasound Contrast Agents.
Wu H; Abenojar EC; Perera R; De Leon AC; An T; Exner AA
Ultrasound Med Biol; 2019 Sep; 45(9):2502-2514. PubMed ID: 31248638
[TBL] [Abstract][Full Text] [Related]
39. Aptamer-conjugated nanobubbles for targeted ultrasound molecular imaging.
Wang CH; Huang YF; Yeh CK
Langmuir; 2011 Jun; 27(11):6971-6. PubMed ID: 21553884
[TBL] [Abstract][Full Text] [Related]
40. Concurrent visual and acoustic tracking of passive and active delivery of nanobubbles to tumors.
Pellow C; Abenojar EC; Exner AA; Zheng G; Goertz DE
Theranostics; 2020; 10(25):11690-11706. PubMed ID: 33052241
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
